119 related articles for article (PubMed ID: 28302450)
21. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
Yeh SA; Wan Leung S; Wang CJ; Chen HC
Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
Hille A; Weiss E; Hess CF
Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
[TBL] [Abstract][Full Text] [Related]
23. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
24. Completion surgery after intensity-modulated arc therapy in the treatment of locally advanced cervical cancer: feasibility, surgical outcome, and oncologic results.
Tummers P; Makar A; Vandecasteele K; De Meerleer G; Denys H; De Visschere P; Delrue L; Villeirs G; Lambein K; den Broecke RV
Int J Gynecol Cancer; 2013 Jun; 23(5):877-83. PubMed ID: 23698797
[TBL] [Abstract][Full Text] [Related]
25. A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality.
Alleyne-Mike K; van Wijk L; Hunter A
Int J Gynecol Cancer; 2013 Sep; 23(7):1287-94. PubMed ID: 23863456
[TBL] [Abstract][Full Text] [Related]
26. Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinoma.
Chen YL; Ho CM; Chen CA; Chiang YC; Huang CY; Hsieh CY; Cheng WF
Int J Gynaecol Obstet; 2011 Feb; 112(2):135-9. PubMed ID: 21130445
[TBL] [Abstract][Full Text] [Related]
27. A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA.
Lee YY; Choi CH; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
Gynecol Oncol; 2011 Mar; 120(3):439-43. PubMed ID: 21145099
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
[TBL] [Abstract][Full Text] [Related]
29. Stage IB cervix cancer with nodal involvement treated with primary surgery or primary radiotherapy: Patterns of failure and outcomes in a contemporary population.
Lapuz C; Kondalsamy-Chennakesavan S; Bernshaw D; Khaw P; Narayan K
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):274-82. PubMed ID: 26549207
[TBL] [Abstract][Full Text] [Related]
30. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
Singh P; Tripcony L; Nicklin J
Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.
Mabuchi S; Okazawa M; Kinose Y; Matsuo K; Fujiwara M; Suzuki O; Morii E; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2012 Oct; 22(8):1389-97. PubMed ID: 22976497
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors and clinicopathologic characteristics of invasive adenocarcinoma of the uterine cervix.
Chargui R; Damak T; Khomsi F; Ben Hassouna J; Chaieb W; Hechiche M; Gamoudi A; Boussen H; Benna F; Rahal K
Am J Obstet Gynecol; 2006 Jan; 194(1):43-8. PubMed ID: 16389008
[TBL] [Abstract][Full Text] [Related]
33. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
34. Role of positive peritoneal cytology in FIGO stage IB to IIB cervical adenocarcinoma.
Han Y; Li N; Zhang R; Li X; Sun Y; Wu L
Int J Gynaecol Obstet; 2017 May; 137(2):150-156. PubMed ID: 28186628
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Hsueh S; Chen CK; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):429-36. PubMed ID: 20542643
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up results of irradiation alone or combined with surgery in stage I-IV carcinoma of the uterine cervix.
Reinartz G; Bartsch S; Willich N
Zentralbl Gynakol; 2000; 122(6):318-23. PubMed ID: 10904995
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
[TBL] [Abstract][Full Text] [Related]
38. Recurrence patterns after radical hysterectomy in stage IB1-IIA cervical.
Sittidilokratna K; Cheewakriangkrai C; Khunamornpong S; Siriaunkgul S
Asian Pac J Cancer Prev; 2010; 11(2):499-502. PubMed ID: 20843140
[TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
